Home/Investors/Epidarex Capital

Epidarex Capital

Biotech Investor · 3 portfolio companies

Portfolio

3

Focus Areas

13

Top Stage

Pre-clinical

Investment Focus

Cystic Fibrosis Asthma COPD Neurodegenerative Diseases Amyotrophic Lateral Sclerosis Frontotemporal Dementia Alzheimer's Disease Parkinson's Disease Huntington's Disease Oncology Inflammatory Diseases Fibrotic Diseases Neurological Conditions

Portfolio Companies

Company	Stage	Valuation	Focus
Enterprise Therapeutics	Phase 1	—	Cystic Fibrosis, Asthma
Libra Therapeutics	Pre-clinical	—	Neurodegenerative Diseases, Amyotrophic Lateral Sclerosis
Macomics	Pre-clinical	—	Oncology, Inflammatory Diseases

Frequent Co-Investors

Versant Ventures1 shared Forbion1 shared Novartis Venture Fund1 shared Dolby Family Ventures1 shared Santé Ventures1 shared IP Group1 shared Panakes Partners1 shared Boehringer Ingelheim Venture Fund1 shared